Carregant...
Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer’s Disease?
While the extensive hunt for therapeutics combating Alzheimer’s disease (AD) has fallen short of delivering effective treatments, breakthroughs towards understanding the disease mechanisms and identifying areas for future research have nevertheless been enabled. The majority of clinical trials with...
Guardat en:
| Publicat a: | Neurotherapeutics |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer International Publishing
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6277284/ https://ncbi.nlm.nih.gov/pubmed/30242774 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-018-0668-6 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|